Drug derived from the hydrangea root shows promise for autoimmune disorders
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston, along with the Harvard School of Dental Medicine.
The Novartis drug Ilaris helps patients with the most severe form of childhood arthritis, according to results from a second late-stage study.